Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Anti-HTLV I gp46 antibody [67/5.5.13.1] (ab9082)

Anti-HTLV I gp46 antibody [67/5.5.13.1] (ab9082)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

You may also be interested in

Product image
Human PEDF ELISA Kit (ab246535)
Product image
Anti-Mutant p53 antibody [Y5] (ab32049)
Product image
Recombinant Human CYB5R2 protein (BSA and azide free) (ab180333)
Anti-LDL (MDA oxidized) [5D8] antibody (ab17591)

Images

  • Flow Cytometry - Anti-HTLV I gp46 antibody [67/5.5.13.1] (ab9082)
    Flow Cytometry - Anti-HTLV I gp46 antibody [67/5.5.13.1] (ab9082) This image is courtesy of an anonymous Abreview
    Flow Cytometry analysis of human MT2 cells (HTLV-1 transformed T-cell line) using ab9082 (1/250). For further information please refer to abreview.

    See Abreview

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-HTLV I gp46 antibody [67/5.5.13.1] (ab9082)

  •  
  • Anti-HTLV I gp46 antibody [68/4.11.21] (ab9083)

    Applications: ELISA, ICC/IF, RIP, WB

  •  
  • Anti-HTLV I gp46 antibody [65/6C2.2.34] (ab9086)

    Applications: ELISA, ICC/IF, RIP, WB

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.